1-4 of 4
Wahid T. Hanna, MD
Close
Sort by
Journal Articles

Risk-Adapted Therapy in Adults with Burkitt Lymphoma: Preliminary Report of a Multicenter Prospective Phase II Study of DA-EPOCH-R

Kieron Dunleavy, MD, Ariela Noy, MD, Jeremy S. Abramson, MD, Ann S. LaCasce, MD, Brian K Link, MD, Samir Parekh, MD, Deepa Jagadeesh, MD MPH, Philip J Bierman, MD, Ronald T. Mitsuyasu, MD, Ramakrishna Battini, MD, Peter R Watson, MD, David Peace, MD, Bruce J Averbrook, MD, Harris V. Naina, MD, Joseph W Leach, MD, Wahid T Hanna, MD, Bayard L. Powell, MD, Sunil Nagpal, MD, Mark Roschewski, MD, Andrea N Lucas, RN, Seth M. Steinberg, PhD, Brad S Kahl, MD, Jonathan W. Friedberg, MD MMSc, Richard F Little, MDMPH, Nancy L Bartlett, MD, Michelle A. Fanale, MD, Wyndham H Wilson, MD PhD
Journal: Blood
Blood (2015) 126 (23): 342.
https://doi.org/10.1182/blood.V126.23.342.342
Published: 2015
Journal Articles

Bortezomib In Combination with Rituximab, Cyclophosphamide, and Prednisone with or without Doxorubicin Followed by Rituximab Maintenance In Patients with Relapsed or Refractory Follicular Lymphoma: Results of a Phase 2 Study.

Michael Craig, MD, Wahid T Hanna, MD, Fernando Cabanillas, MD, Chien-Shing Chen, MD, PhD, Sudha Parasuraman, MD, Rachel Neuwirth, MS, Owen A. O'Connor, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2798.
https://doi.org/10.1182/blood.V116.21.2798.2798
Published: 2010
Journal Articles

Open Synovectomy and Open Reduction with Internal Fixation of Right Distal Femur Fracture in a Pediatric High Titer Factor VIII Inhibitor Patient under Cover of rFVIIa.

Wahid T. Hanna, MD, Cameron J. Sears, MD
Journal: Blood
Blood (2005) 106 (11): 4101.
https://doi.org/10.1182/blood.V106.11.4101.4101
Published: 2005
Journal Articles

Recombinant Activated Factor VII (rFVIIa)-Mediated Normalization of INR Levels Post-Coumadin Overdose.

Wahid T. Hanna, MD
Journal: Blood
Blood (2005) 106 (11): 4102.
https://doi.org/10.1182/blood.V106.11.4102.4102
Published: 2005